Navigation Links
Industrial Solvent May Increase Risk for Parkinsonism
Date:1/11/2008

Study links trichloroethylene exposure to nervous system disorder

FRIDAY, Jan. 11 (HealthDay News) -- Exposure to a common industrial solvent known as trichloroethylene may raise the risk for developing parkinsonism, a group of nervous system disorders with symptoms similar to Parkinson's disease, new research suggests.

Although the study focused on people working close to a source of trichloroethylene (TCE), the solvent has been found in drinking water, surface water and soil near sites where it's used, the researchers noted.

In the study, University of Kentucky researchers initially assessed three Parkinson's disease patients who'd been exposed to TCE at work for at least 25 years. Questionnaires were then sent to 134 of their factory co-workers.

The researchers found that 14 former workers who worked close to the TCE source exhibited signs of parkinsonism. This included having significantly slower fine motor hand movements than people the same age who hadn't been exposed to TCE.

Another 13 former workers who worked in the same area or slightly farther from the TCE source reported no signs of parkinsonism. However, their fine motor movements were still significantly slower than people of a similar age who were not exposed to TCE.

In additional studies with rats, the researchers found that TCE exposure inhibited mitochondrial function in the substantia nigra, an area of the brain that produces dopamine, a chemical that sends signals that control movement.

The findings were published online recently in the Annals of Neurology.

More information

The American Academy of Family Physicians has more about Parkinson's disease.



-- Robert Preidt



SOURCE: Annals of Neurology, news release, Jan. 7, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
2. American Pacific Management to Present at CIBC World Markets 2nd Industrials Conference
3. Roper Industries to Present at the Robert W. Baird Industrial Conference
4. Biolytix to Offer Industrial Gene Expression Analysis and Genotyping Services Using Affymetrix GeneChip(R) Technology
5. Robbins & Myers to Present at Merrill Lynch Growth Industrials Conference December 13, 2007
6. US ranks last among other industrialized nations on preventable deaths
7. New study: US ranks last among other industrialized nations on preventable deaths
8. Industrial Solvent May Increase Risk for Parkinsons Disease
9. Smoking may strongly increase long-term risk of eye disease
10. Diabetes appears to increase risk of death for patients with acute coronary syndromes
11. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Industrial Solvent May Increase Risk for Parkinsonism
(Date:12/9/2016)... NY (PRWEB) , ... December 09, 2016 , ... ... and Drug Dependence, Inc. (NCADD) is recommending the film Whispering Spirits ... and the District of Columbia as an education tool in the war against teen ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... Pierre Hotel in New York, NY, on December 3rd, to benefit Holy Name ... attended the annual event, which raised over $1 million - the largest event ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Quality Insights beginning January 1, 2017. The name change aligns the entire ... measuring and improving health care quality. , “We are very proud of the ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental ... dentists and patients about the safety issues related to dental restorations. According to the ... is projected to reach $6.4 billion in 2018 with more than 30 million Americans ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... DIEGO , Dec. 9, 2016 aTyr Pharma, Inc. ... discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, ... at the upcoming BMO Prescriptions for Success Healthcare Conference at the ... on Wednesday, December 14, 2016, at 4:20 p.m. ET. ... ...
(Date:12/9/2016)... , Dec. 9, 2016  Axovant Sciences Ltd. ... biopharmaceutical company focused on the treatment of dementia, ... from a Phase 2b trial evaluating treatment with ... compared with donepezil plus placebo in people with ... addition of intepirdine to treatment was associated with ...
(Date:12/8/2016)... , Dec. 8, 2016 Australia Glaucoma ... GlobalData,s new report, "Australia Glaucoma Surgery Devices ... on the Australia Glaucoma Surgery Devices market. The ... volume (in units) and average prices (USD) within ... report also provides company shares and distribution shares ...
Breaking Medicine Technology: